Hanish Arnold C's Form 4/A amendment
AmendedDecoy Therapeutics Inc. (DCOY) · filed Jun 6, 2022
- Accession no.
- 0001615219-22-000093
- Filed
- Jun 6, 2022
- Trade date
- Aug 21, 2020
- Filing delay
- 654 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 24, 2020
This filing lists 1 non-derivative transaction. Open-market purchases total $3.92K. It was filed 654 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hanish Arnold CCIK 0001233253 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2020 | Common Stock | PPurchaseAcquired | +4,000 | $0.98 | +$3,920 | 11,350 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on August 24, 2020 to reflect that the securities reported are indirectly beneficially owned as indicated herein.